Clinical trial
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
NCT05100368 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
- Lead sponsor
- Istituto Ortopedico Rizzoli
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 2, 2021
- Completion date
- July 1, 2021
- Enrollment
- 1,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.